LabStyle Innovations Corp. (DRIO), today announced that its Dario™ Diabetes Management Solution was featured in a national broadcast news segment in Australia. The Dario was recently launched in Australia following regulatory and reimbursement approval in that country.
Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the t:slim® and t:flex™ Insulin Pumps, today announced that it has entered into non-exclusive Development Agreements with Dexcom, Inc. to allow the integration of future generation Tandem insulin pumps with the Dexcom G5 and G6 continuous glucose monitoring ("CGM") systems.
#connected device
#cgm
#insulin pump
Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the t:slim® and t:flex™ Insulin Pumps, today reported its financial results for the quarter ended June 30, 2015. As of June 30, 2015, the Company had $99.7 million in cash, cash equivalents and short-term investments. Operating loss for the second quarter of 2015 was $18.7 million, compared to $18.3 million for the same period of 2014. This included non-cash, stock-based compensation of $3.3 million for the quarter ended June 30, 2015, compared to $3.5 million for the same period of 2014. For the second quarter of 2015, operating expenses increased 8 percent to $23.5 million from $21.8 million for the same period of 2014.
Some 4 million patients globally will remotely monitor their health conditions by 2020, up from 664,000 patients in 2014, according to a new report from IHS Technology. About 120,300 patients were monitoring diabetes remotely in 2014 and this number of patients will grow at a CAGR of 35 percent to 712,800 in 2020.
#rpm
One of the leaders in the diabetes management market is turning to Google to make its blood glucose sensors smaller and more appealing to diabetics. And with some 10 percent of the American population dependent on those sensors to manage their chronic condition, that's a sizeable market to address. San Diego-based Dexcom's partnership with Google's Life Sciences division is designed to create "something that is very, very low cost and very small," Dexcom Vice President Steve Pacelli told Forbes. "Add all that together with a robust data platform. … Diabetes management is largely predicated on having data to make better decisions."
#r&d
#cgm
WellDoc and Samsung will bring a new version of WellDoc's BlueStar mobile prescription therapy for diabetes to 300 Toronto citizens in partnership with the Ontario Telemedicine Network (OTN), a Canadian government-funded nonprofit. The new offering, BlueStar-S, will combine features of BlueStar and Samsung S Health.
#product & service
#mobile app
Sweden-based company Diabetes Tools, which has developed a mobile, clinical diabetes management service, called TriabetesClinic, has acquired a consumer-facing diabetes tracking app for children, called DiabetesGuru, from its developer, Shore Innovation.
#product & service
#mobile app
Google Life Science's recently-announced partnership with Dexcom have already made it clear that diabetes is a focus for the company. Now the company is making that focus official in a new partnership with Sanofi and the Joslin Diabetes Center.
#r&d
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly adjusted revenues of $3.133 billion for the third fiscal quarter ended June 30, 2015, an increase of 45.2 percent over the prior-year period as reported, or 55.6 percent on a currency-neutral basis. On a comparable, currency-neutral basis, adjusted revenues grew 2.4 percent. As reported, revenues were $3.120 billion
Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the t:slim® and t:flex™ Insulin Pumps, was recently named among the Best Places to Work in San Diegofor 2015. The list is published each year by the San Diego Business Journal.